Icon plc Stock
The price for the Icon plc stock decreased slightly today. Compared to yesterday there is a change of -€0.300 (-0.200%).
With 21 Buy predictions and not a single Sell prediction Icon plc is an absolute favorite of our community.
With a target price of 203 € there is a positive potential of 33.11% for Icon plc compared to the current price of 152.5 €.
Pros and Cons of Icon plc in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | -0.200% | -4.028% | 9.673% | -22.569% | -25.791% | -13.842% | - |
| Alkermes plc | 0.000% | -1.653% | -4.800% | -18.493% | -15.000% | 1.623% | 35.227% |
| Ironwood Pharmaceuticals | -4.050% | -9.554% | 7.576% | -14.458% | -32.381% | -75.004% | -70.872% |
| Novocure Ltd | 2.000% | -7.868% | 8.408% | -64.776% | -63.204% | -84.730% | -91.827% |
Comments
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for ICLR provided by MarketBeat
News
3 Healthcare Pathbreakers With Long-Term Tailwinds
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (NASDAQ:ICLR) by selling 16,096 shares. The transaction was valued at $2.58 million
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the
